Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Instromedix gets Japanese marketing approval:

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health and Welfare has approved Instromedix' (US) range of ambulatory cardiac event monitors for sale in Japan. The average hospital stay for cardiac care in Japan is 21 days, compared with seven in the US. At $16,700 million Japan is the third largest market for medtech products after the US and Europe.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel